MIGUEL A RIVERA

Allopathic & Osteopathic Physicians|Otolaryngology|Otolaryngology/Facial Plastic Surgery BRANDON, FL NPI 1699860122

General Payments — all program years on this page

$2,545.20

  • Category: General Payments
  • Program years: PY2018–2024
  • Record count: 71
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $765.33 across 17 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $666.9916
Education $98.341

By paying entity

Latest program year (PY2024) · sorted by reported total.

Paying entityAmountRecords
Regeneron Healthcare Solutions, Inc. $354.195
Neurent Medical Limited $165.791
GlaxoSmithKline, LLC. $100.355
OptiNose US, Inc. $98.094
Circassia Inc. $23.991
Medtronic, Inc. $22.921

By program year

Program yearAmountRecords
2018 $348.2115
2019 $734.7016
2020 $132.885
2021 $66.544
2022 $315.846
2023 $181.708
2024 $765.3317

Records — PY2024 (17)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1082354141 Circassia Inc. $23.99 02/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1098837360 Neurent Medical Limited $165.79 01/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114147379 Regeneron Healthcare Solutions, Inc. $98.34 01/23/2024 Education Undisputed 01/23/2026 View at CMS
1114147381 Regeneron Healthcare Solutions, Inc. $116.91 01/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114147383 Regeneron Healthcare Solutions, Inc. $24.72 05/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114147385 Regeneron Healthcare Solutions, Inc. $27.16 08/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1114147387 Regeneron Healthcare Solutions, Inc. $87.06 08/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115900182 GlaxoSmithKline, LLC. $20.11 09/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1115965646 GlaxoSmithKline, LLC. $19.91 07/15/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116356998 GlaxoSmithKline, LLC. $20.11 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116509309 GlaxoSmithKline, LLC. $20.11 06/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1116648855 GlaxoSmithKline, LLC. $20.11 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1119440801 Medtronic, Inc. $22.92 07/24/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142186760 Optinose US, Inc. $24.46 06/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142186774 Optinose US, Inc. $25.29 05/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142186792 Optinose US, Inc. $29.15 03/21/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1142186824 Optinose US, Inc. $19.19 08/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.